Drug Price Control Order
- All
- News
- Videos
-
Centre Not Considering Change In Essential Drugs' Pricing Policy
Government is also working to bring a new method to decide prices of 'new drugs' to avoid delays in launching them in the market.
-
Price Cap On Stents Hailed By All, But Serious Concerns Remain
The drug pricing regulator has directed that in cases of evidence of artificial stent shortage, the state governments can proceed against the manufacturers and seize their stent stocks as per the provisions of the Drug Price Control Order, 2013.
-
Pharmaceutical Pricing Body Fixes, Revises Prices Of 18 Essential Drugs
As stipulated under the Drugs (Prices Control) Order (DPCO) 2013, NPPA fixes ceiling price of essential medicines of Schedule I.
-
Price Cap On Stents Hailed By All, But Serious Concerns Remain
The drug pricing regulator has directed that in cases of evidence of artificial stent shortage, the state governments can proceed against the manufacturers and seize their stent stocks as per the provisions of the Drug Price Control Order, 2013.
-
Drug Pricing Regulator Fixes Prices Of 33 Essential Drugs
In respect of medicines not under price control, manufacturers are allowed to increase the maximum retail price by 10 per cent annually.
-
Drug Pricing Regulator To Soon Fix Ceiling Rates Of Stents
The Department of Pharmaceuticals has in a notification put bare metal stents and drug eluting stents (DES) in the Schedule I of DPCO 2013.
-
Government To Amend Norms In 15 Days For Fixing Prices Of 350 Drugs
Drugs Prices Control Order will be amended in the next 15 days to enable the regulator NPPA to fix prices of about 350 medicines whose market data is not available, Union Minister Ananth Kumar said today.
-
Government To Amend Norms For Fixing Prices Of 350 Drugs In 15 Days
Drugs Prices Control Order will be amended in the next 15 days to enable the regulator NPPA to fix prices of about 350 medicines whose market data is not available, Union Minister Ananth Kumar said on Monday.
-
Drug Price Regulator Issues Notices To Firms For Violating Pricing Control Order
"We have issued notices to top 10 firms that have not registered their products under IPDMS and will be also be issuing notices to others," NPPA Chairman Bhupendra Singh said.
-
Drug Pricing: Don't Take Coercive Steps Against Cipla, Others, Says Court
The Delhi High Court on Tuesday told the government not to take any coercive action against pharmaceutical companies including Novartis India Limited and Cipla Ltd in connection with the notices issued to them for allegedly not ensuring implementation of the revised drug pricing of 2013.
-
Government Forms Committee to Review Drug Pricing Policy
As stipulated under DPCO 2013, drug price regulator NPPA fixes the ceiling price of essential medicines of schedule-I.
-
Pharma Sector Growth May Remain Strong: Icra
Growth momentum of the domestic pharmaceuticals sector is likely to sustain in the near to medium term owing to steady demand witnessed across therapy segments, regular new launches and price hikes taken by companies, a report by rating agency Icra has said.
-
Government Wants to Beef Up Drug Price Order: Report
The government is reviewing the Drug (Prices Control) Order, 2013, to sort out implementation issues and make it more efficient - both for consumers and the industry.
-
Put Drug Price Related Information in Public Domain: Minister to Regulator
The system aims to facilitate online submission of mandatory returns and reports under the Drug Price Control Order (DPCO), 2013 by manufacturers, including companies which make, import, distribute or sell drugs in the country.
-
Price Controls: Pharma Industry Favours Dialogue With Government, Says Report
After failing to get a stay order from the Delhi High Court on the latest round of drug price control order, the pharmaceuticals industry has called for a dialogue with the regulators to resolve the row, saying such issues are best ironed out through dialogues than in court rooms.
-
Centre Not Considering Change In Essential Drugs' Pricing Policy
Government is also working to bring a new method to decide prices of 'new drugs' to avoid delays in launching them in the market.
-
Price Cap On Stents Hailed By All, But Serious Concerns Remain
The drug pricing regulator has directed that in cases of evidence of artificial stent shortage, the state governments can proceed against the manufacturers and seize their stent stocks as per the provisions of the Drug Price Control Order, 2013.
-
Pharmaceutical Pricing Body Fixes, Revises Prices Of 18 Essential Drugs
As stipulated under the Drugs (Prices Control) Order (DPCO) 2013, NPPA fixes ceiling price of essential medicines of Schedule I.
-
Price Cap On Stents Hailed By All, But Serious Concerns Remain
The drug pricing regulator has directed that in cases of evidence of artificial stent shortage, the state governments can proceed against the manufacturers and seize their stent stocks as per the provisions of the Drug Price Control Order, 2013.
-
Drug Pricing Regulator Fixes Prices Of 33 Essential Drugs
In respect of medicines not under price control, manufacturers are allowed to increase the maximum retail price by 10 per cent annually.
-
Drug Pricing Regulator To Soon Fix Ceiling Rates Of Stents
The Department of Pharmaceuticals has in a notification put bare metal stents and drug eluting stents (DES) in the Schedule I of DPCO 2013.
-
Government To Amend Norms In 15 Days For Fixing Prices Of 350 Drugs
Drugs Prices Control Order will be amended in the next 15 days to enable the regulator NPPA to fix prices of about 350 medicines whose market data is not available, Union Minister Ananth Kumar said today.
-
Government To Amend Norms For Fixing Prices Of 350 Drugs In 15 Days
Drugs Prices Control Order will be amended in the next 15 days to enable the regulator NPPA to fix prices of about 350 medicines whose market data is not available, Union Minister Ananth Kumar said on Monday.
-
Drug Price Regulator Issues Notices To Firms For Violating Pricing Control Order
"We have issued notices to top 10 firms that have not registered their products under IPDMS and will be also be issuing notices to others," NPPA Chairman Bhupendra Singh said.
-
Drug Pricing: Don't Take Coercive Steps Against Cipla, Others, Says Court
The Delhi High Court on Tuesday told the government not to take any coercive action against pharmaceutical companies including Novartis India Limited and Cipla Ltd in connection with the notices issued to them for allegedly not ensuring implementation of the revised drug pricing of 2013.
-
Government Forms Committee to Review Drug Pricing Policy
As stipulated under DPCO 2013, drug price regulator NPPA fixes the ceiling price of essential medicines of schedule-I.
-
Pharma Sector Growth May Remain Strong: Icra
Growth momentum of the domestic pharmaceuticals sector is likely to sustain in the near to medium term owing to steady demand witnessed across therapy segments, regular new launches and price hikes taken by companies, a report by rating agency Icra has said.
-
Government Wants to Beef Up Drug Price Order: Report
The government is reviewing the Drug (Prices Control) Order, 2013, to sort out implementation issues and make it more efficient - both for consumers and the industry.
-
Put Drug Price Related Information in Public Domain: Minister to Regulator
The system aims to facilitate online submission of mandatory returns and reports under the Drug Price Control Order (DPCO), 2013 by manufacturers, including companies which make, import, distribute or sell drugs in the country.
-
Price Controls: Pharma Industry Favours Dialogue With Government, Says Report
After failing to get a stay order from the Delhi High Court on the latest round of drug price control order, the pharmaceuticals industry has called for a dialogue with the regulators to resolve the row, saying such issues are best ironed out through dialogues than in court rooms.
